DRCR.net Protocol Review -

The live program has concluded.

If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.

Scroll back to top

Details

Overview
This continuing medical education (CME) activity captures content from a roundtable meeting held in December 2015. This certified CME activity is for retina specialists and general ophthalmologists involved in the management of patients with retinal disease.Jointly provided by Evolve Medical Education LLC, New Retina MD, and Retina Today. Supported through an unrestricted educational grant by Regeneron Pharmaceuticals
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Discuss the ocular and systemic effects of anti-VEGF therapies in patients with diabetes and how to educate patients on appropriate expectations
- Assess clinical studies involving new approaches to treat DME and proliferative diabetic retinopathy
- Use expert case examples to differentiate between clinical study dosing protocols and alternative dosing schedules
- Evaluate treatment options and develop a treatment regimen that can reduce patient burden and practice capacity
Accreditation
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC, New Retina MD, and Retina Today. Evolve Medical Education LLC is accredited by the ACCME to provide continuing medical education for physicians. CREDIT
DESIGNATION STATEMENT
Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™ . Physicians should claim only the credit commensurate with the extent of their participation.
Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
R.V. Paul Chan, MD, MSc, FACS St. Giles associate professor of pediatric retina Director of the retina service Weill Cornell Medical College Adjunct associate professor of ophthalmology Columbia University College of Physicians and Surgeons New York, New York Jorge A. Fortun, MD Assistant professor of ophthalmology Bascom Palmer Eye Institute, University of Miami Miller School of Medicine Miami, Florida Geeta A. Lalwani, MD Vitreoretinal surgeon Rocky Mountain Retina Associates Boulder, Colorado Andrew A. Moshfeghi, MD, MBA Director of the clinical trials unit Associate professor of ophthalmology Keck School of Medicine, University of Southern California Los Angeles, California Dante J. Pieramici, MD Partner in California Retina Consultants Director of the California Retina Research Foundation Santa Barbara, California Charles C. Wykoff, MD, PhD Co-director of research at Retina Consultants of Houston Deputy chair of ophthalmology, Blanton Eye Institute, Houston Methodist Hospital Houston, Texas
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, New Retina MD, Retina Today, or Regeneron Pharmaceuticals.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date: 04/30/2017